Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 19, 2019 - Issue 3
Submit an article Journal homepage
585
Views
16
CrossRef citations to date
0
Altmetric
Review

Management of immune-related adverse events resulting from immune checkpoint blockade

Barouyr BaroudjianDermatology Department, Saint-Louis Hospital, Paris, FranceView further author information
,
Dimitri ArangalageUniversité Paris 7 Diderot, Sorbonne, Paris, France;Department of Cardiology, INSERM U1148, Bichat Hospital, Paris, FranceView further author information
,
Stefania CuzzubboUniversité Paris 7 Diderot, Sorbonne, Paris, France;Neurology Department, Saint-Louis Hospital, Paris, FranceView further author information
,
Baptiste HervierInternal Medecine and immunology Department, Centre National de Référence des Maladies Musculaires, Pitié-Salpêtrière Hospital, Paris, FranceView further author information
,
Celeste LebbéDermatology Department, Saint-Louis Hospital, Paris, France;Université Paris 7 Diderot, Sorbonne, Paris, France;INSERM U976, Paris, FranceORCID Iconhttps://orcid.org/0000-0002-5854-7290View further author information
ORCID Icon,
Gwenael LorillonPneumology Department, Centre National de Référence de l’Histiocytose Langerhansienne, Saint-Louis Hospital, Paris, FranceView further author information
,
Abdellatif TaziUniversité Paris 7 Diderot, Sorbonne, Paris, France;INSERM UMR-1153 (CRESS), Biostatistics and Clinical Epidemiology Research Team (ECSTRA), Paris, FranceView further author information
,
Gerard ZalcmanUniversité Paris 7 Diderot, Sorbonne, Paris, France;Thoracic Oncology Department, Bichat-Claude Bernard Hospital, Paris, FranceView further author information
,
Mohamed BouattourDigestive Oncology Department, Beaujon Hospital, Clichy, FranceView further author information
,
Frédéric LiotéUniversité Paris 7 Diderot, Sorbonne, Paris, France;Rheumatology Department, INSERM UMR 1132, Lariboisière Hospital, Paris, FranceView further author information
,
Jean-François GautierUniversité Paris 7 Diderot, Sorbonne, Paris, France;Endocrinology Department, Lariboisière Hospital, Paris, FranceView further author information
,
Solenn BrosseauThoracic Oncology Department, Bichat-Claude Bernard Hospital, Paris, FranceView further author information
,
Nelson LourencoGastro-enterology Department, Saint-Louis Hospital, Paris, FranceView further author information
,
Julie DelyonDermatology Department, Saint-Louis Hospital, Paris, France;Université Paris 7 Diderot, Sorbonne, Paris, France;INSERM U976, Paris, FranceCorrespondence[email protected]
View further author information
& the PATIO group show all
Pages 209-222 | Received 12 Aug 2018, Accepted 19 Dec 2018, Published online: 09 Jan 2019

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Pavlos Msaouel, Giannicola Genovese, Jianjun Gao, Suvajit Sen & Nizar M. Tannir. (2021) TAM kinase inhibition and immune checkpoint blockade– a winning combination in cancer treatment?. Expert Opinion on Therapeutic Targets 25:2, pages 141-151.
Read now

Articles from other publishers (15)

O. Peyrony, S. Mathé, S. Addou, N. Naud, I. Madelaine, B. Baroudjian, C. Lebbé & J.-P. Fontaine. (2023) Toxicités immuno-induites chez les patients avec cancer sous immunothérapie par inhibiteurs des checkpoints . Ce que l’urgentiste doit savoir . Annales françaises de médecine d’urgence 13:4, pages 241-253.
Crossref
Marcelo Sandoval, Adriana H. Wechsler, Zahra Alhajji, Jayne Viets-Upchurch, Patricia Brock, Demis N. Lipe, Aisha Al-breiki & Sai-Ching J. Yeung. (2023) Evaluation and management of acute high-grade immunotherapy-related neurotoxicity. Heliyon 9:3, pages e13725.
Crossref
Yihua Liu, Li Zheng, Xingjuan Cai, Xiaojun Zhang & Yang Ye. (2023) Cardiotoxicity from neoadjuvant targeted treatment for breast cancer prior to surgery. Frontiers in Cardiovascular Medicine 10.
Crossref
Kevin C.J. Yuen, Susan L. Samson, Irina Bancos, Aidar R. Gosmanov, Sina Jasim, Leslie A. Fecher & Jeffrey S. Weber. (2022) American Association of Clinical Endocrinology Disease State Clinical Review: Evaluation and Management of Immune Checkpoint Inhibitor-Mediated Endocrinopathies: A Practical Case-Based Clinical Approach. Endocrine Practice 28:7, pages 719-731.
Crossref
Luca Patti, Laura Musso, Diego Ferone & Manuela Albertelli. (2022) Inibitori dei checkpoint immunitari e patologia tiroidea. L'Endocrinologo 23:2, pages 125-132.
Crossref
A.S. Mochalova, E.S. Koneva, A.V. Tsvetkova, M.O. Senchilov, A.L. Bedzhanyan, G.A. Shatveryan & E.V. Batukhtina. (2022) Comprehensive rehabilitation of immune-mediated adverse events in cancer patients receiving checkpoint inhibitor therapy. Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury 99:4, pages 30.
Crossref
Koichi Takeda, Kenji Nakano, Shohei Udagawa, Naoki Fukuda, Aya Nishizawa, Makiko Ono, Tetsuya Urasaki, Junichi Tomomatsu, Toshiaki Mochizuki, Taro Shiga, Takahiro Kogawa, Shunji Takahashi & Shigehisa Kitano. (2022) Chilblain lupus-like cutaneous reaction associated with systemic lupus erythematosus induced by immune checkpoint inhibitor. Rheumatology 61:1, pages e13-e14.
Crossref
Ling Zhan, Hong-fang Feng, Han-qing Liu, Lian-tao Guo, Chuang Chen, Xiao-li Yao & Sheng-rong Sun. (2021) Immune Checkpoint Inhibitors-Related Thyroid Dysfunction: Epidemiology, Clinical Presentation, Possible Pathogenesis, and Management. Frontiers in Endocrinology 12.
Crossref
Kieran Adam, Alina Iuga, Anna S. Tocheva & Adam Mor. (2021) A novel mouse model for checkpoint inhibitor-induced adverse events. PLOS ONE 16:2, pages e0246168.
Crossref
Nikhila Kethireddy, Steffi Thomas, Poorva Bindal, Prateek Shukla & Upendra Hegde. (2020) Multiple autoimmune side effects of immune checkpoint inhibitors in a patient with metastatic melanoma receiving pembrolizumab. Journal of Oncology Pharmacy Practice 27:1, pages 207-211.
Crossref
Stefania Cuzzubbo, Pauline Tetu, Sarah Guegan, Renata Ursu, Catherine Belin, Lila Sirven Villaros, Julie Mazoyer, Coralie Lheure, Celeste Lebbe, Barouyr Baroudjian & Antoine F Carpentier. (2020) Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients. Journal for ImmunoTherapy of Cancer 8:2, pages e001034.
Crossref
Omid Kooshkaki, Afshin Derakhshani, Negar Hosseinkhani, Mitra Torabi, Sahar Safaei, Oronzo Brunetti, Vito Racanelli, Nicola Silvestris & Behzad Baradaran. (2020) Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials. International Journal of Molecular Sciences 21:12, pages 4427.
Crossref
Subashini Sharon Gnanendran, Lauren Maree Turner, James Austin Miller, Shelley Ji Eun Hwang & Andrew Charles Miller. (2020) Cutaneous Adverse Events of Anti-PD-1 Therapy and BRAF Inhibitors. Current Treatment Options in Oncology 21:4.
Crossref
N. Haddad, T. Vidal‐Trecan, B. Baroudjian, A.‐M. Zagdanski, D. Arangalage, M. Battistella, J.‐F. Gautier, C. Lebbe & J. Delyon. (2019) Acquired generalized lipodystrophy under immune checkpoint inhibition. British Journal of Dermatology 182:2, pages 477-480.
Crossref
Erwan Le Tallec, Alain Lescoat, Alice Ballerie, Bérengère Cador, Hervé Lena, Charles Ricordel, Sène Damien, Céleste Lebbe, Patrick Jego & Nicolas Belhomme. (2020) Eosinophilic Fasciitis Triggered by Nivolumab: A Remarkable Efficacy of the mTOR Inhibitor Sirolimus. Journal of Thoracic Oncology 15:2, pages e29-e30.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.